Ukrainian government threatens to impose ban on imports of foreign drugs

The Ukrainian government is considering imposing a ban on the imports of up to 136 drugs to the country, whose manufacturers do not have Good Manufacturing Practice (GMP) certificate of quality, confirmed by the Ukrainian National Drug Service.

Among the potentially affected companies are leading generic drug producers as Teva Pharmaceutical Industries, STADA Arzneimittel, Actavis and Sopharma, Bionorica, Orion Pharma and others. Most of them have already expressed their protest against the actions of the Ukrainian government, since the ban threatens multimillion losses for them.

According to the companies, the Ukrainian government selectively confirmed international certificates, artificially restricting drug imports from abroad, in favor of local producers. The affected companies have also explained that certification of some enterprises is unprofitable for them, due to the fact that the volume of production at their facilities is small.